However, both biomarkers, fibrinogen and albumin, are synthesized in the liver, so the prognostic value of these single biomarkers alone is limited in patients with hepatic insufficiency (e.g., cancer, malnutrition, or chronic heart failure). The gene discussed is ALB; the disease is Hepatic failure.